PNC Financial Services Group
IMNM icon

PNC Financial Services Group’s Immunome IMNM Stock Holding History

PNC Financial Services Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3K Sell
655
-205
-24% -$4.56K ﹤0.01% 3826
2025
Q4 		$18.5K Buy
860
+309
+56% +$5.42K ﹤0.01% 3706
2025
Q3 		$6.45K Buy
551
+198
+56% +$1.97K ﹤0.01% 4117
2025
Q2 		$3.28K Hold
353
– – ﹤0.01% 4264
2025
Q1 		$2.38K Hold
353
– – ﹤0.01% 4295
2024
Q4 		$3.75K Hold
353
– – ﹤0.01% 4115
2024
Q3 		$5.16K Buy
+353
New +$5.02K ﹤0.01% 4030

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

PNC Financial Services Group's IMNM Position: Q1 2026 in Review

PNC Financial Services Group reduced its Immunome (IMNM) stake by 24% in Q1 2026, selling an estimated $4.56K and leaving 655 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.

PNC Financial Services Group first reported a position in IMNM in Q3 2024 and has held it in 7 quarters since. The position peaked at $18.5K in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • PNC Financial Services Group held 655 shares of Immunome worth $14.3K as of Q1 2026.
  • PNC Financial Services Group sold 205 Immunome shares in Q1 2026, an estimated $4.56K.
  • Immunome made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3826 holding.
  • PNC Financial Services Group first reported a position in Immunome in Q3 2024 and has held it in 7 quarters since.
  • PNC Financial Services Group's Immunome position peaked at $18.5K in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.